ENTERO vs LENSKART: Stock Comparison
LENSKART SOLUTIONS is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows a lower P/E, while LENSKART SOLUTIONS shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ENTERO leads 4; LENSKART leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ENTERO | LENSKART |
|---|---|---|
| Sector | Consumer Services | Consumer Services |
| Industry | Pharmacy Retail | Speciality Retail |
Price
| Metric | ENTERO | LENSKART |
|---|---|---|
| Live Price | ₹1,503.9 | ₹639.95 |
| Day Change | -5.12% | -1.01% |
| Volume | 1.65 L | 17.88 L |
| 52-Week High | ₹1,920 | ₹725 |
| 52-Week Low | ₹944 | ₹356.1 |
| Distance from 52W High | -21.67% | -11.73% |
Valuation
| Metric | ENTERO | LENSKART |
|---|---|---|
| Market Cap | ₹6,558 Cr | ₹1.11 L Cr |
| P/E Ratio | 52.28x | 169.77x |
| P/B Ratio | 3.88x | 12.72x |
| EPS | ₹8.77 | ₹1.28 |
| Book Value | ₹402.67 | ₹50.91 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ENTERO | LENSKART |
|---|---|---|
| Revenue Growth (TTM YoY) | 42.6% | 45.6% |
| EPS Growth (TTM YoY) | 9.1% | -10.8% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | ENTERO | LENSKART |
|---|---|---|
| ROE | 1.6% | 9.2% |
| ROCE | 2.01% | 11.89% |
| Net Margin | 1.75% | 5.6% |
| Operating Margin | 9.99% | 11.92% |
| Debt to Equity | 0.06x | 0.02x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ENTERO | LENSKART |
|---|---|---|
| Promoter Holding | 14.4%▼ 0.01 pp | 17.52%▼ 0.01 pp |
| FII Holding | 4.37%▲ 0.34 pp | 18.26%▲ 5.5 pp |
| DII Holding | 15.48%▼ 1.14 pp | 26.82%▲ 3.25 pp |
| Public Holding | 27.75%▲ 0.82 pp | 36.98%▼ 8.74 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and LENSKART SOLUTIONS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.